MoneyInvestor's Business Daily
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.
Amgen beat Wall Street's top- and bottom-line expectations late Tuesday, but there were puts and takes across the board. The post Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say. appeared first on Investor's Business Daily.
Join the argument
House rules →Comments load as you scroll.